About
A Global Dissolution Research Presentations
Competition for Young Pharmaceutical Researchers.
Follow Us
©Copyright 2023 SPDS India. All Rights Reserved.
Designed and maintained by Soni Digital
| Sr | Poster No. | Abstract title |
| 1 | P01 | A multistage dissolution strategy to mimic biorelevant conditions for different generic products of BCS class II compound with pH dependent solubility. |
| 2 | P04 | Comparative in-vitro release of Risperidone loaded long acting microspheres with marketed formulation |
| 3 | P05 | Computational Modeling and Simulation of Alternative Setups for Drug Dissolution |
| 4 | P09 | Designing, Sintering and Profiling of fixed-dose anti-tuberculosis drugs loaded 3D printlets using selective laser sintering (SLS) additive manufacturing technology |
| 5 | P12 | Dissolution Assisted Interpretation of High Efficacy of ATIS-ARM-LUM - Long Acting Intramuscular Injection |
| 6 | P13 | Drug Loading Influences Amorphous-Amorphous Phase Separation (AAPS)-mediated nanodroplet formation during dissolution of Amorphous Solid Dispersions (ASDs) |
| 7 | P17 | Enhancing Topical Permeability of A Potent Immunosuppressant via Lipidic Nanosystems For Effective Management of Rheumatoid Arthritis |
| 8 | P18 | Evaluating the efficiency of biphasic media to characterize the dissolution profile of albumin-based injectable nanoparticle. |
| 9 | P19 | Exploring High Permeation Vesicles-Mediated Transdermal Delivery of Methotrexate for Rheumatoid Arthritis Treatment |
| 10 | P21 | Exploring the polymer-excipient amalgamation in supersaturable Loratadine ternary amorphous solid dispersion for enhanced in-vitro and in-vivo performance |
| 11 | P23 | Improvement of Drug Release from Colloidal Silicon Dioxide incorporated Empagliflozin Ocular Insert: monitoring of IOP and IVIVC |
| 12 | P29 | Ionic Liquid-Based Ionogel for Transdermal Delivery of Etodolac for the Treatment of Rheumatoid Arthritis |
| 13 | P32 | Modulating Dissolution and Permeability of Acetazolamide through Cocrystallization: Insights from Molecular Dynamics |
| 14 | P35 | QbD-Driven Development of Sublingual Alfuzosin for Improved BPH Therapy |
| Sr | Poster No. | Abstract Title |
| 1 | M02 | Artificial in-vitro Blood-Brain Barrier (BBB) model for preclinical screening |
| 2 | M05 | Development & evaluation of topical quercetin loaded bilosomal gel formulation for psoriasis |
| 3 | M17 | Evaluation of Erlotinib ionogel as a non-invasive yet localized breast cancer therapy |
| 4 | M19 | Exploration of conventional and FDM-mediated 3D printed tablets fabricated using HME based filaments for pH dependent drug delivery |
| 5 | M20 | Exploring the Potential of Nanosuspensions in Enhancing the Dissolution Profile and Oral Bioavailability of Gefitinib |
| 6 | M21 | Exploring the Potential of Polymeric Micellar Gel for Enhancing the Efficacy of Adapalene and Benzoyl Peroxide for the Treatment of Acne |
| 7 | M29 | Formulation development and efficacy study of nanoparticles for nose to brain delivery |
| 8 | M33 | In vitro Release testing (IVRT) method development of Ganciclovir nanocarrier based in situ ophthalmic gel using USP Apparatus Type IV |
| 9 | M35 | Investigating the Potential of Nanostructured Lipid Carriers in Oral Bioavailability Enhancement of Venetoclax |
| 10 | M37 | LC-MS/MS Analysis - A Sensitive and Specific Bioanalytical Tool for IVPT Studies by Partial Media Replacement Method - Case Study with 5%w/w Acyclovir Cream |
| 11 | M38 | Long Acting Aqua Triggered In situ gelling Meloxicam Injection |
| 12 | M39 | Modified 3D printed dissolution cell of USP type-4 apparatus: Novel approach for accelerated dissolution testing of In-situ gel formulations. |
A Global Dissolution Research Presentations
Competition for Young Pharmaceutical Researchers.
©Copyright 2023 SPDS India. All Rights Reserved.
Designed and maintained by Soni Digital